GSK CEO on acquisition of biotech firm IDRx
0
0
13/01/25
Dans
Amérique du Nord / États-Unis
Emma Walmsley, GSK CEO, joins 'Money Movers' to discuss the company's deal to acquire IDRx, the impact of Robert F. Kennedy Jr.'s administration position, and much more.
Montre plus
0 commentaires
sort Trier par
